Patricia Woodard

Title: Patricia Woodard: Innovator in Sulfonamide Research

Introduction

Patricia Woodard is a prominent inventor based in Sugar Land, TX (US). She has made significant contributions to the field of biotechnology, particularly in the development of sulfonamides and their derivatives. With a total of 4 patents, her work focuses on modulating the activity of endothelin peptides, which play a crucial role in various physiological processes.

Latest Patents

Woodard's latest patents include innovative formulations of sulfonamides that target endothelin-mediated disorders. These patents detail methods for inhibiting the binding of endothelin peptides to their receptors, utilizing compounds such as N-(isoxazolyl)thienylsulfonamides, N-(isoxazolyl)furylsulfonamides, and N-(isoxazolyl)pyrrolylsulfonamides. Her research provides valuable insights into treating conditions associated with endothelin activity by administering effective amounts of these sulfonamides or their prodrugs.

Career Highlights

Woodard is affiliated with Texas Biotechnology Corporation, where she continues to advance her research in sulfonamide formulations. Her work has garnered attention for its potential applications in treating endothelin-mediated disorders, showcasing her commitment to improving therapeutic options in biotechnology.

Collaborations

Some of her notable coworkers include Natalie Blok and Chengde Wu, who contribute to the collaborative efforts in her research endeavors.

Conclusion

Patricia Woodard's innovative work in sulfonamide research exemplifies her dedication to advancing biotechnology. Her contributions have the potential to significantly impact the treatment of endothelin-mediated disorders, highlighting her role as a leading inventor in this field.